Faculty of Medicine-Ain Shams University
Cairo, Abbasia, 1181, Egypt
NCT Number: NCT06255873
This study was conducted on thirty children aged from12 months to 18 years newly diagnosed with drug resistant epilepsy and following up at Pediatric Nutrition and Neurology Outpatient Clinics assigned randomly into 2 groups, group1: patients who started ketogenic diet with L-carnitine and group2: patients who started ketogenic diet only.
Looking for future studies?
Notify Me12 month–18 year
All sexes
Interventional
Not applicable
Cairo, Abbasia, 1181, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
L-carnitine was taken after feeds in the form of tablets or dissolved tablets in a dose of 50 mg/kg/day, with maximum dose of 2 g/day.
ketogenic diet (KD) initiated under supervision of expert physician who considered patient's age, type of feeding, needs and preferences of the child and his/her family to select the type and initial ratio of KD therapy, KD ratio ranged from 1:1 to 4:1 of lipids to carbohydrates plus proteins in grams.
Time frame: At time of enrollment and 3 months of intervention.
Antral length measurement using abdominal ultrasonography.
Ain Shams University
Other
Effects of L-Carnitine Supplementation on Gastric Emptying in Children With Drug Resistant Epilepsy on Ketogenic Diet
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06911879
Body Weight, Caloric Restriction
Amman, Jordan
View Trial DetailsNCT06449287
Acid-Base Imbalance, Acidosis
Columbus, Ohio, United States
View Trial DetailsNCT06432231
Behavior, Brain Diseases
Çiğli, İ̇zmi̇r, Turkey (Türkiye)
View Trial DetailsNCT00476125
Behavior, Fasting
Boston, Massachusetts, United States
View Trial Details